HCPCS Level IItemporaryActive
Q0155
Dronabinol (syndros) 0.1 mg
BETOS: O1D
Effective: 2025-01-01
Referenced in 1 policies
Description
Dronabinol (syndros), 0.1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
Drug Products
FDA-registered drug products mapped to this HCPCS code
SYNDROS 5 MG/1 ML
NDC: 78613-0201-30PO